Le marché mondial de l’immunodiagnostic atteindra 22 732,7 millions de dollars américains d’ici la fin de 2025 ; Augmenter le pouvoir d’achat des consommateurs pour propulser le marché, selon Fortune Business Insights

Le nombre croissant de populations gériatriques et la survenue de maladies infectieuses comme le cancer et l’hépatite devraient stimuler le marché mondial de l’immunodiagnostic. Selon un rapport publié par Fortune Business Insights, intitulé « Immunodiagnostics : Global Market Analysis, Insights, and Forecast, 2018-2025 », le marché était évalué à 15 777,5 millions de dollars US en 2017. Fortune Business Insights prévoit que le marché augmentera à un TCAC de 4,7% et atteindre 22 732,7 millions de dollars d’ici la fin de 2025.

Obtenez la brochure PDF de ce rapport @ www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444

Certaines des principales entreprises qui opèrent sur le marché mondial de l’immunodiagnostic sont

  • Abbott,
  • Hoffmann-La Roche AG (Roche Diagnostics),
  • Diasorine,
  • Société Danaher,
  • QIAGEN,
  • bioMérieux,
  • Thermo Fisher Scientific,
  • Diagnostic de quête.

Développements clés de l’industrie

  • En mars 2019, Oncimmune a annoncé l’acquisition de Protagen Diagnostics.
  • En novembre 2018, Ortho Clinical Diagnostics a reçu l’approbation de la FDA des États-Unis pour le test VITROS HIV Combo de la société, un immunodiagnostic qui détecte les anticorps (Ab) du VIH-1 et du VIH-2 et l’antigène p24 (Ag).
  • En mai 2016, Diasorin a annoncé l’acquisition des produits d’immunodiagnostic de Quest Diagnostics.

Le système immunitaire d’un humain est l’un des réseaux les plus complexes. Les avancées récentes sur le marché mondial de l’immunodiagnostic ont improvisé le diagnostic de ce réseau complexe. Une augmentation des maladies infectieuses comme le VIH, le cancer, l’hépatite et d’autres maladies cardiovasculaires contribue à l’expansion du marché de l’immunodiagnostic. En outre, les progrès technologiques alimenteront la croissance du marché mondial de l’immunodiagnostic au cours de la période de prévision. Le rapport fournit une analyse approfondie de divers facteurs qui ont contribué à la croissance du marché mondial de l’immunodiagnostic.

Achat rapide

www.fortunebusinessinsights.com/checkout-page/100444

Le segment de l’oncologie et de l’endocrinologie connaîtra une demande croissante

Le marché de l’immunodiagnostic est classé en oncologie et endocrinologie, tests de maladies infectieuses, tests d’hépatite et de rétrovirus et tests de selles gastro-intestinales en termes d’application. En 2017, le segment de l’oncologie et de l’endocrinologie avait généré une part de marché de 25,6%. La part la plus élevée du segment est accréditée pour l’adoption de l’immunodiagnostic dans diverses applications, à savoir les maladies endocriniennes et le cancer. Il y a eu une augmentation du nombre de remboursements de produits ainsi que d’approbations de nouveaux produits. En outre, plusieurs tests devraient propulser le marché mondial de l’immunodiagnostic d’ici la fin de 2025.

Avez-vous une question ? Demandez à nos experts :

www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunodiagnostics-market-100444

L’Asie-Pacifique restera dominante sur le marché

The global immunodiagnostics market can be geographically segmented into Latin America, North America, Asia Pacific, Middle East, Europe and Africa. Amongst these regions, the Asia Pacific market was worth US$ 3,949.1 Mn in 2017, and it is still likely to generate a comparatively high CAGR during the forecast period. As there is an increasing awareness among the masses regarding disease management, it encourages them to go for regular health check-ups and tests. This has also enhanced the global immunodiagnostics market.

Moreover, an increasing number of players in the region, rising awareness, and advancements in health care industry will drive the immunodiagnostics market in Asia Pacific. It is anticipated that China and India will exhibit high demand for immunodiagnostics in Asia Pacific. This is because of the presence of unmet medical needs in the region. The immunodiagnostics market in the Middle East and Latin America is projected to expand considerably by the end of 2025, because of the rise in infectious and cardiovascular diseases in these regions.

Secondary Data Sources That We Refer To

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
  • Industry journals and paid databases

Secondary Research Is Conducted To Derive The Following Information

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.

Segmentation

By Product

  • Instruments
  • Reagents & Consumables

By Application

  • Oncology & Endocrinology
  • Hepatitis & Retrovirus
  • Cardiac Markers
  • Infectious Diseases
  • Others

By End user

  • Clinical Laboratories
  • Hospitals
  • Physician’s Offices
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Abbott, DiaSorin, and Roche Diagnostics are Likely to Hold Significant Share in the Market

Prominent organizations such as Abbott, DiaSorin, and Roche Diagnostics are projected to lead the global immunodiagnostics market during the forecast period. Development strategies, rise in the investments in research and development, cost management, and strong supply chain network are predicted to give impetus to these companies and enable them gain a competitive edge.

Highlights of the Report

  • In-depth analysis of various insights, namely, Immunodiagnostics Market, growth drivers, opportunities, and other related challenges.
  • Comprehensive details of key market players, their core competencies, and market shares.
  • The potency of suppliers and buyers to make better business decisions.
  • Lists out the market size in terms of volume.

KEY QUESTIONS ANSWERED:

What is the market size and growth rate of the global and regional market by various segments?

What is the market size and growth rate of the market for selective countries?

Which region or sub-segment is expected to drive the market in the forecast period?

What Factors are estimated to drive and restrain the market growth?

What are the key technological and market trends shaping the market?

What are the key opportunities in the market?

What are the key companies operating in the market?

Which company accounted for the highest market share?

Why Choose Fortune Business Insights?

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Enquête n° 36, Baner,

Autoroute Pune-Bangalore,

Pune – 411045, Maharashtra, Inde.

Téléphone:

États-Unis :+1 424 253 0390

Royaume-Uni : +44 2071 939123

APAC : +91 744 740 1245

Courriel : [email protected]

Linkedin | Twitter | Blogues